ARS Pharmaceuticals Inc (NASDAQ:SPRY)

6.33
Delayed Data
As of Jan 30
 +0.01 / +0.16%
Today’s Change
2.80
Today|||52-Week Range
9.17
-25.79%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Shawver Laura K
Chief Executive Officer
Buy8/05/202278,740$1.27$100.0K+21.92%
Odegard Valerie
President & Chief Scientific Officer
Gift2/01/202216,406$0.00$0.00+30.72%
Shawver Laura K
Chief Executive Officer
Gift2/01/202227,500$0.00$0.00+30.72%
Hunder Naomi
Chief Medical Officer
Gift2/01/202211,250$0.00$0.00+30.72%
Piazza Jonathan
Chief Financial Officer
Gift2/01/202211,250$0.00$0.00+30.72%
Hawkinson Russell
Senior Vice President-Finance
Gift2/01/20227,500$0.00$0.00+30.72%
Hawkinson Russell
Senior Vice President-Finance
Gift5/02/202228,335$0.00$0.00+101.27%
Hunder Naomi
Chief Medical Officer
Gift5/02/202243,177$0.00$0.00+101.27%
Odegard Valerie
President & Chief Scientific Officer
Gift5/02/202245,233$0.00$0.00+101.27%
Piazza Jonathan
Chief Financial Officer
Gift5/02/202243,691$0.00$0.00+101.27%
Page of 2